Science News

Top U.S. scientists are concerned that eye and vision health are relatively absent from national health priority lists. AMD, in particular, is rising..

Currently there is no treatment available for advanced dry AMD that can cause vision loss, also known as geographic atrophy. However, BrightFocus-funded researchers are working on the early stages of a possible solution.

BrightFocus-sponsored research at the University of Luxembourg has identified a gene that may provide a new starting point for developing treatments for Alzheimer's disease.

BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.

Jeffrey Goldberg, MD, PhD, a BrightFocus grantee answers questions about an exciting new clinical trial for glaucoma.

More and more people are paying attention to lifestyle changes aimed at keeping the brain healthy, and helping to keep Alzheimer’s at bay. Not a total solution, but one that could help.